{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T08:55:51Z","timestamp":1700643351620},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1998,3,1]],"date-time":"1998-03-01T00:00:00Z","timestamp":888710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[1998,3]]},"DOI":"10.1007\/bf01452263","type":"journal-article","created":{"date-parts":[[2005,4,12]],"date-time":"2005-04-12T19:48:15Z","timestamp":1113335295000},"page":"148-151","source":"Crossref","is-referenced-by-count":9,"title":["Polyarthritis, rash and lymphadenopathy: Case reports of two patients with angioimmunoblastic lymphadenopathy presenting to a rheumatology clinic"],"prefix":"10.1007","volume":"17","author":[{"given":"M. A.","family":"Layton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Musgrove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. T.","family":"Dawes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0140-6736(74)90553-4","volume":"1","author":"G Frizzera","year":"1974","unstructured":"Frizzera G, Moran EM, Rappaport H.. Angio-immunoblastic lymphadenopathy with dysproteinaemia. Lancet 1974;1:1070?3.","journal-title":"Lancet"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/ard.46.7.555","volume":"46","author":"NJ McHugh","year":"1987","unstructured":"McHugh NJ, Campbell GJ, Landreth JJ, Laurent MR. Polyarthritis and angioimmunoblastic lymphadenopathy. Ann Rheum Dis 1987;46:555?8.","journal-title":"Ann Rheum Dis"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/art.1780330417","volume":"33","author":"DT Boumpas","year":"1990","unstructured":"Boumpas DT, Wheby MS, Jaffe ES, et al. Synovitis in angioimmunoblastic lymphadenopathy with dysproteinaemia simulating rheumatoid arthritis. Arthritis Rheum 1990;33:578?82.","journal-title":"Arthritis Rheum"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/oxfordjournals.annonc.a059281","volume":"6","author":"W Siegert","year":"1995","unstructured":"Siegert W, Nerl C, Agthe A, et al. Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. Ann Oncol 1995;6:659?64.","journal-title":"Ann Oncol"},{"key":"CR5","first-page":"435","volume":"53","author":"R Bistue","year":"1993","unstructured":"Bistue R, Scognamillo C, Lovato G, et al. Seropositive polyarthritis as a presentation form of angioimmunoblastic lymphadenopathy. Medicina 1993;53:435?8.","journal-title":"Medicina"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0090-1229(76)90061-1","volume":"6","author":"W Pruzanski","year":"1976","unstructured":"Pruzanski W, Sutton DM, Pantolony D. Angioimmunoblastic lymphadenopathy: an immunochemical study. Clin Immunol Immunopathol 1976;6:62?76","journal-title":"Clin Immunol Immunopathol"},{"key":"CR7","first-page":"151","volume":"189","author":"MH Cullen","year":"1979","unstructured":"Cullen MH, Stansfield AG, Oliver RTD, et al. Angio-immunoblastic lymphadenopathy: report of ten cases and review of the literature. Q J Med 1979;189:151?77.","journal-title":"Q J Med"},{"key":"CR8","first-page":"56","volume":"24","author":"K Ozoran","year":"1995","unstructured":"Ozoran K, Turgay M, Kinikli G, et al. Angioimmunoblastic lymphadenopathy with disproteinaemia arising in a patient with rheumatoid arthritis. Scand J Rheumatol 1995;24:56?8.","journal-title":"Scand J Rheumatol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0049-0172(86)90048-X","volume":"16","author":"ED Rosenstein","year":"1986","unstructured":"Rosenstein ED, Wieczorac R, Raphael BG, Agus B. SLE and angioimmunoblastic lymphadenopathy: case report and review of the literature. Semin Arthritis Rheum 1986;16:146?51.","journal-title":"Semin Arthritis Rheum"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/annonc\/2.suppl_2.163","volume":"2","author":"H Stein","year":"1991","unstructured":"Stein H. Peripheral T-cell lymphomas. Ann Oncol 1991;2:163?70.","journal-title":"Ann Oncol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"364","DOI":"10.7326\/0003-4819-117-5-364","volume":"117","author":"W Siegert","year":"1992","unstructured":"Siegert W, Agathe A, Griesser H, et al. Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisolone with or without the COPBLAM\/IMVP-16 regimen. A multicentre study. Kiel Lymphoma Study Group. Ann Intern Med 1992;117:364?70.","journal-title":"Ann Intern Med"},{"key":"CR12","first-page":"713","volume":"84","author":"M Natale Di","year":"1993","unstructured":"Di Natale M, Biagioni P, Grassi M, et al. Angioimmunoblastic lymphadenopathy with dysproteinaemia: personal experience with 3 cases and review of the literature. Minerva Medica 1993;84:713?8.","journal-title":"Minerva Medica"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/cncr.2820690531","volume":"69","author":"A Ohsaka","year":"1992","unstructured":"Ohsaka A, Saito K, Sakai T, et al. Clinicopathologic and therapeutic aspects of angioimmunoblastic lymphadenopathy-related lesions. Cancer 1992;69:1259?67.","journal-title":"Cancer"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1002\/1097-0142(19920515)69:10<2567::AID-CNCR2820691029>3.0.CO;2-M","volume":"69","author":"T Murayama","year":"1992","unstructured":"Murayama T, Imoto S, Takahashi T. et al. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinaemia with cyslosporin A. Cancer 1992;69:2567?70.","journal-title":"Cancer"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01452263.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01452263\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01452263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T18:25:58Z","timestamp":1556821558000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01452263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,3]]}},"alternative-id":["BF01452263"],"URL":"https:\/\/doi.org\/10.1007\/bf01452263","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,3]]}}}